Live Breaking News & Updates on Davidr Guyer

Stay updated with breaking news from Davidr guyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Monashee Investment Management LLC Takes $4.04 Million Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)

Monashee Investment Management LLC bought a new stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 175,000 shares of the company’s stock, valued at approximately $4,044,000. EyePoint Pharmaceuticals accounts for about 0.7% of Monashee […] ....

Robertw Baird , Davidr Guyer , Securities Exchange Commission , Quarter For Eyepoint Pharmaceuticals , Investment Advisers , Deutsche Bank , Eyepoint Pharmaceuticals Company Profile , China Universal Asset Management Co , Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Inc , Mirae Asset Global Investments Co , News Ratings For Eyepoint Pharmaceuticals Daily , Monashee Investment Management , Eyepoint Pharmaceuticals Stock Performance , Toth Financial Advisory Corp , Insider Activity At Eyepoint Pharmaceuticals , Free Report , Point Pharmaceuticals , Investment Management , Asset Global Investments , Financial Advisory Corp , China Universal Asset Management , Director David , Exchange Commission , Cormorant Asset Management , One Financial ,

Merck eyes purchase of ophthalmology company

In addition to augmenting Merck’s pipeline, the company said, the acquisition significantly expands the company’s presence in ophthalmology. ....

United States , New Jersey , David Guyer , Tony Adamis , Davidr Guyer , Eyebiotech Limited Eyebio , Eyebiotech Limited , Eyebio Board , Hart Scott Rodino Antitrust Improvements Act , Generally Accepted Accounting Principles ,

Merck to Acquire EyeBio

Merck to Acquire EyeBio
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Kate Bingham , Tony Adamis , David Guyer , Bernard Davitian , Davidr Guyer , Amir Zamani , Mike Ross , Andreas Wallnoefer , Christine Brennan , Biocapital Srini Akkaraju , Sv Health Investors , Centerview Partners , Meagher Flom , Dunn Crutcher , Ventures Fund Olga Danilchanka , Exchange Commission , Merck Co Inc , Statement Of Merck Co Inc , Merck Research Laboratories , Eyebiotech Limited Eyebio , Eyebio Eyebiotech , Bain Capital Life Sciences Leonard Feiner , Sv Health Investors Kate Bingham , Eyebiotech Limited ,

Merck to Buy EyeBio, for Up To USD3 Billion

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

City Of , United Kingdom , Amir Zamani , Mike Ross , Andreas Wallnoefer , Christine Brennan , Davidr Guyer , Biocapital Srini Akkaraju , Bernard Davitian , Sv Health Investors Kate Bingham , Ventures Fund Olga Danilchanka , Bain Capital Life Sciences Leonard Feiner , Eyebiotech Limited , United Kingdom Based , Kate Bingham , Samsara Biocapital , Srini Akkaraju , Jeito Capital , Olga Danilchanka , Bain Capital Life Sciences , Leonard Feiner , Omega Funds , Vertex Ventures ,

Merck to Acquire EyeBio for Up to $3B, Re-Entering Eye Drug Space

Merck to Acquire EyeBio for Up to $3B, Re-Entering Eye Drug Space
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , Anthonyp Adamis , Davidr Guyer , November Eyebio , Eyebiotech Eyebio , Dame Kate Bingham , David Guyer , Asia Pacific , Mike Ross , Sv Health Investors , Pharmaceuticals To Akorn , Merck Co , Merck Research Laboratories , Bristol Myers Squibb , Bain Capital Life Sciences , Akorn Pharmaceuticals , Ono Pharmaceutical , Inspire Pharmaceuticals , Japan Based Santen Pharmaceutical , Specialty Care , United Kingdom Vaccine Taskforce , Samsara Biocapital , Jeito Capital , Last November Eyebio , Omega Funds ,